Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial

Author： Anghelescu I. Szegedi A. Schlegel S. Weigmann H. Hiemke C. Wetzel H.

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.8, Iss.4, 1998-12, pp. : 315-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Memantine for the Treatment of Alzheimer's Disease: Tolerability and Safety Data from Clinical Trials

By Farlow Martin R.

Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. : 577-585

Adis International

Access to resources Recommend Favorite

Despite safety concerns, clozapine has a unique profile of clinical benefits in patients with treatment-resistant schizophrenia or schizophrenia-associated suicidality

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 10, 2007-10 ,pp. : 9-13

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Conjunctivitis: Data from Six Clinical and Phase I Safety Studies

By Comstock Timothy L.

Clinical Drug Investigation, Vol. 30, Iss. 10, 2010-10 ,pp. : 675-685

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of a Fixed Combination of Cinnarizine and Dimenhydrinate in Treatment of Vertigo: Analysis of Data from Five Randomised, Double-Blind Clinical Studies

By Schremmer D.

Clinical Drug Investigation, Vol. 18, Iss. 5, 1999-11 ,pp. : 355-368

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Tianeptine in Major Depression: Evidence from a 3-Month Controlled Clinical Trial versus Paroxetine

By Waintraub L.

CNS Drugs, Vol. 16, Iss. 1, 2002-01 ,pp. : 65-75

Adis International

Access to resources Recommend Favorite